September 24, 2010

12:00 noon

Registration Opens/Lunch

1:00 p.m.

Welcome and Introductions
Mark A. Crowther, MD, FRCPC
Program Co-Chair

Michael E. Williams, MD
Program Co-Chair

1:10 p.m.

Myelodysplastic Syndromes
James M. Foran, MD
University of Alabama Birmingham

1:50 p.m.

Myeloproliferative Disorders
Ruben A. Mesa, MD
Mayo Clinic in Rochester

2:30 p.m.

Panel Discussion

3:00 p.m.

Break and Exhibits Open

3:20 p.m.

New Antithrombotic Agents
Kenneth A. Bauer, MD
Beth Israel Deaconess Medical Center

4:00 p.m.

Managing Excessive Anticoagulation and Anticoagulating the Patient at High Risks of Bleeding
David Garcia, MD
University of New Mexico

4:40 p.m.

Antiphospholipid Antibody Syndrome
Mark Crowther, MD
McMaster University

5:20 p.m.

Panel Discussion

5:50 p.m.

Program Concludes for the Day

September 25, 2010

7:00 a.m.

Breakfast With the Experts
(Speakers and Attendees)

8:00 a.m.

Introductions and Announcements

8:05 a.m.

Practice Update

8:15 a.m.

Chronic Lymphocytic Leukemia
Clive Zent, MD
Mayo Clinic in Rochester

8:55 a.m.

Myeloma: Front Line Therapy
A. Keith Stewart, MD
Mayo Clinic in Phoenix/Scottsdale

9:35 a.m.

Panel Discussion

10:05 a.m.

Break and Exhibits Open

10:25 a.m.

Diffuse Large B-Cell Lymphoma
John W. Sweetenham, MD
Cleveland Clinic

11:05 a.m.

Follicular Lymphoma
Jane Winter, MD
Northwestern University

11:45 a.m.

Mantle Cell Lymphoma
Michael E. Williams, MD
University of Virginia

12:25 p.m.

Panel Discussion

12:55 p.m.

Lunch and Exhibits Open

2:00 p.m.

Peripheral T-Cell Lymphoma
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center

2:40 p.m.

PET Imaging: Current Guidelines and Caveats in DLBCL
Bruce D. Cheson, MD
Georgetown University

3:20 p.m.

Panel Discussion

3:50 p.m.

Symposium Adjourned